Next Article in Journal
Invasive Fungal Infections Associated with COVID-19
Next Article in Special Issue
Mucormycosis: A 14-Year Retrospective Study from a Tertiary Care Center in Lebanon
Previous Article in Journal
Characterization of the Community of Black Meristematic Fungi Inhabiting the External White Marble of the Florence Cathedral
Previous Article in Special Issue
Targeting the P10 Peptide in Maturing Dendritic Cells via the DEC205 Receptor In Vivo: A New Therapeutic Strategy against Paracoccidioidomycosis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JoF
Volume 9
Issue 6
10.3390/jof9060666
jof-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit Patients from Poland

by
Magdalena Skóra
1,*,
Mateusz Gajda
1,
Magdalena Namysł
2,
Jerzy Wordliczek
3,
Joanna Zorska
4,5,
Piotr Piekiełko
6,7,
Barbara Żółtowska
8,
Paweł Krzyściak
1,
Piotr B. Heczko
1 and
Jadwiga Wójkowska-Mach
1
1
Chair of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, Czysta 18 Street, 31-121 Krakow, Poland
2
Department of Microbiology, University Hospital in Krakow, Macieja Jakubowskiego 2 Street, 30-688 Krakow, Poland
3
Interdisciplinary Intensive Care Clinic, Jagiellonian University Medical College, Macieja Jakubowskiego 2 Street, 30-688 Krakow, Poland
4
Center for Innovative Medical Education, Jagiellonian University Medical College, Medyczna 7 Street, 30-688 Krakow, Poland
5
Intensive Care Unit, University Hospital in Krakow, Macieja Jakubowskiego 2 Street, 30-688 Krakow, Poland
6
Department of Internal Diseases and Circulatory Failure, Center of Pulmonology and Thoracic Surgery in Bystra, Juliana Fałata 2 Street, 43-360 Bystra, Poland
7
Department of Pulmonology and Respiratory Failure, Center of Pulmonology and Thoracic Surgery in Bystra, Juliana Fałata 2 Street, 43-360 Bystra, Poland
8
Center for Innovative Therapy, Clinical Research Coordination Center, University Hospital in Krakow, Macieja Jakubowskiego 2 Street, 30-688 Krakow, Poland
*
Author to whom correspondence should be addressed.
J. Fungi 2023, 9(6), 666; https://doi.org/10.3390/jof9060666
Submission received: 7 May 2023 / Revised: 7 June 2023 / Accepted: 11 June 2023 / Published: 13 June 2023
(This article belongs to the Special Issue Young Investigator in Fungal Infections, 2nd Edition)
Browse Figure
Review Reports Versions Notes

Abstract

Coronavirus disease 2019 (COVID-19) has been shown to be a favoring factor for aspergillosis, especially in a severe course requiring admission to the intensive care unit (ICU). The aim of the study was to assess the morbidity of CAPA among ICU patients in Poland and to analyze applied diagnostic and therapeutic procedures. Medical documentation of patients hospitalized at the temporary COVID-19 dedicated ICU of the University Hospital in Krakow, Poland, from May 2021 to January 2022 was analyzed. In the analyzed period, 17 cases of CAPA were reported with an incidence density rate of 9 per 10 000 patient days and an incidence rate of 1%. Aspergillus fumigatus and Aspergillus niger were isolated from lower respiratory samples. Antifungal therapy was administered to 9 patients (52.9%). Seven patients (77.8%) received voriconazole. The CAPA fatality case rate was 76.5%. The results of the study indicate the need to increase the awareness of medical staff about the possibility of fungal co-infections in ICU patients with COVID-19 and to use the available diagnostic and therapeutic tools more effectively.
Keywords: Aspergillus; COVID-associated pulmonary aspergillosis; CAPA; invasive aspergillosis; SARS-CoV-2 Aspergillus; COVID-associated pulmonary aspergillosis; CAPA; invasive aspergillosis; SARS-CoV-2

Share and Cite

MDPI and ACS Style

Skóra, M.; Gajda, M.; Namysł, M.; Wordliczek, J.; Zorska, J.; Piekiełko, P.; Żółtowska, B.; Krzyściak, P.; Heczko, P.B.; Wójkowska-Mach, J. COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit Patients from Poland. J. Fungi 2023, 9, 666. https://doi.org/10.3390/jof9060666

AMA Style

Skóra M, Gajda M, Namysł M, Wordliczek J, Zorska J, Piekiełko P, Żółtowska B, Krzyściak P, Heczko PB, Wójkowska-Mach J. COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit Patients from Poland. Journal of Fungi. 2023; 9(6):666. https://doi.org/10.3390/jof9060666

Chicago/Turabian Style

Skóra, Magdalena, Mateusz Gajda, Magdalena Namysł, Jerzy Wordliczek, Joanna Zorska, Piotr Piekiełko, Barbara Żółtowska, Paweł Krzyściak, Piotr B. Heczko, and Jadwiga Wójkowska-Mach. 2023. "COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit Patients from Poland" Journal of Fungi 9, no. 6: 666. https://doi.org/10.3390/jof9060666

APA Style

Skóra, M., Gajda, M., Namysł, M., Wordliczek, J., Zorska, J., Piekiełko, P., Żółtowska, B., Krzyściak, P., Heczko, P. B., & Wójkowska-Mach, J. (2023). COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit Patients from Poland. Journal of Fungi, 9(6), 666. https://doi.org/10.3390/jof9060666

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop